Familial hypercholesterolaemia: open trials in Poland

2 open trials have a site in Poland. Registry data; only the trial team decides who can take part.

2024-514523-42-00
Comparison of inclisiran or alirocumab to standard therapy in pediatric heterozygous familial hypercholesterolemia (HeFH) – the head-to-head PICOLO-FH clinical trial
Trial Treatment · Phase 3 · Medical University Of Lodz
Uniwersyteckie Centrum Kliniczne, Gdansk · Instytut Centrum Zdrowia Matki Polki, Lodz · Wojewodzki Specjalistyczny Szpital Im Dr Wl Bieganskiego, Lodz
Registry updated 2026-10-30
NCT06597019
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Bialystok · Gdansk · Lodz
Registry updated 2026-05-15

This page is not medical advice. Talk to your doctor before contacting a trial.

Comparison of inclisiran or alirocumab to standard therapy in pediatric heterozygous familial hypercholesterolemia (HeFH) – the head-to-head PICOLO-FH clinical trial